0001127602-15-028796.txt : 20151007
0001127602-15-028796.hdr.sgml : 20151007
20151007171610
ACCESSION NUMBER: 0001127602-15-028796
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151005
FILED AS OF DATE: 20151007
DATE AS OF CHANGE: 20151007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ehrich Elliot
CENTRAL INDEX KEY: 0001376548
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 151149556
MAIL ADDRESS:
STREET 1: 88 SIDNEY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-10-05
0001520262
Alkermes plc.
ALKS
0001376548
Ehrich Elliot
852 WINTER ST.
WALTHAM
MA
02451
1
EVP, R&D & CMO, Alkermes, Inc.
Ordinary Shares
2015-10-05
4
A
0
5000
0
A
36302
D
Ordinary Shares
2015-10-05
4
F
0
2356
59.77
D
33946
D
Performance Restricted Stock Units
2015-10-05
4
A
0
5000
0
A
Ordinary Shares
5000
5000
D
Each performance restricted stock unit represents a contingent right to receive one ordinary share of Alkermes plc.
Represents the earned but unvested portion of the performance restricted stock units granted to the reporting person on March 3, 2014. Fifty percent of the earned performance restricted stock units vested on October 5, 2015 and are included in Table I of this Form 4; the remaining fifty percent of the earned performance restricted stock units are included in Table II of this Form 4 and will vest on October 5, 2016. The performance restricted stock units were earned based on the Food and Drug Administration's approval of ARISTADA? (aripiprazole lauroxil).
/s/ Jennifer Baptiste, attorney-in-fact for Elliot Ehrich
2015-10-07